Advertisement

European Journal of Clinical Pharmacology

, Volume 27, Issue 3, pp 265–268 | Cite as

Bucindolol: Effects on blood pressure, airways resistance and serum creatine phosphokinase

  • J. S. Gill
  • D. G. Beevers
Originals

Summary

The effect of bucindolol on pulse, blood pressure and airways resistance was studied in eight patients. One hour after 150 mg bucindolol, a significant decrease in supine, standing and post-exercise blood pressure was observed. No change in blood pressure occurred 10 to 14 h after doses ranging from 50–150 mg indicating that bucindolol has a relatively short duration of action. A dose related inhibition of excercise induced tachycardia was observed consistant with beta-receptor blocking activity. However, there was no change in the resting pulse indicating partial sympathomimetic activity. There was no increase in airways resistance at all doses of bucindolol. Serum creatine phosphokinase increased beyond normal limits in 3 out of 6 patients studied, probably due to a direct effect upon skeletal muscle.

Key words

bucindolol beta-receptor blockade airways resistance creatine phosphokinase blood pressure ISA alpha-receptor blockade 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Deitchman D, Perhach JL Jr, Snyder RW (1980) B-Adrenoceptor and cardiovascular effects of MJ 13105 (Bucindolol) in anaesthetised dogs and rats. Eur J Pharmacol 61: 263–277Google Scholar
  2. 2.
    Deitchman D (1978) Effects of MJ 13105 on beta-adrenoceptor activity in vivo. Bristol Myers Data Document DEIT-D-07632Google Scholar
  3. 3.
    McNeill RS (1964) Effect of a beta-adrenoceptor blocking agent, propranolol on asthmatics. Lancet 2: 1101–1102Google Scholar
  4. 4.
    Decalmer PBS, Chatterjee SS, Cruickshank JM, Benson MK, Sterling GM (1978) Beta-blockers and asthma. Br Heart J 40: 184–189Google Scholar
  5. 5.
    Formgren M (1976) The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics. Br J Clin Pharmacol 3: 1007–1014Google Scholar
  6. 6.
    Kneussl MP, Richardson JB (1978) Alpha-adrenergic receptors in human and canine tracheal and bronchial smooth muscle. J Appl Physiol 45: 307–311Google Scholar
  7. 7.
    Patel KR, Kerr JW, McDonald EB, McKensie AM (1976) The effect of thymoxamine and cromolyn sodium on post exercise bronchoconstriction in asthma. J Allergy Clin Immunol 57: 285–292Google Scholar
  8. 8.
    Farmer JB, Kennedy I, Levy GP, Marshall MJ (1972) Pharmacology of AH 5158; a drug which blocks both alpha and beta-adrenoceptors. Br J Pharmacol 45: 660–675Google Scholar
  9. 9.
    Jackson SHD, Beevers DG (1983) Comparison of the effects of single doses of atenolol and labetolol on airways obstruction in patients with hypertension and asthma. Br J Clin Pharmacol 15: 553–556Google Scholar
  10. 10.
    Deitchman D (1978) Intrinsic sympathomimetic activity (ISA) of MJ 13105. Bristol Myers Data Document, DEIT-D-07632Google Scholar
  11. 11.
    Braselton JP (1980) Effects of bucindolol, propranolol, aminophylline, salbutamol, atenolol and pindolol on pulmonary ventilation pressure, blood pressure and heart rate in urethane anaesthetised rat. Bristol-Myers Data Document, BRAS-JP-08486Google Scholar
  12. 12.
    Raffin RE, McIntyre ELM, McIntyre KM, Latimer HE, Wood AJ, Crockett, Alpers JH (1982) Assessment of β-adrenoceptor antagonists in asthmatic patients. Br J Clin Pharmacol 13 [Suppl 2]: 325S-335SGoogle Scholar
  13. 13.
    Kumana CR, Marlin GE, Kaye CM, Smith DM (1974) New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J 4: 444–447Google Scholar
  14. 14.
    Forfar JC, Brown GJ, Cull RE (1979) Proximal myopathy during beta-blockade. Br Med J 2: 1331–1332Google Scholar
  15. 15.
    Teicher A, Rosenthal T, Kissin E, Sarova I (1981) Labetalol-induced toxic myopathy. Br Med J 282: 1824–1825Google Scholar
  16. 16.
    Seki A, Takahashi N, Fujii J (1981) Elevation of serum creatine phosphokinase during pindolol treatment. Tohoku J Exp Med 133: 363–364Google Scholar
  17. 17.
    Blessing W, Walsh JC (1977) Myotonia precipitated by propranolol therapy. Lancet 1: 73–74Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • J. S. Gill
    • 1
  • D. G. Beevers
    • 1
  1. 1.University Department of MedicineDudley Road HospitalBirminghamEngland

Personalised recommendations